Skip to main navigation Skip to search Skip to main content

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomona

Project: Research

Project Details

StatusFinished
Effective start/end date02/20/13 → 03/20/14

Funding

  • Gilead Sciences Incorporated: $7,529.20